However, at the neuromuscular junction (NMJ) of transgenic mice lacking major subsets of gangliosides ( Fig. 1) , we have previously shown that presence of the complete family of gangliosides is not strictly required for functional synaptic transmission. Electrophysiological measurement of acetylcholine (ACh) release at NMJs of GM2/GD2-synthase knockout (GM2s-KO), GD3-synthase knockout (GD3s-KO), or compound null-mutant mice lacking both GM2/GD2-and GD3-synthase (dKO), showed only subtle changes and no failure of synaptic transmission was observed (Bullens et al., 2002; Zitman et al., 2008; Zitman et al., 2009 ). This suggests a fine-tuning role for gangliosides in transmitter release, rather than their presence being an absolute requirement. Alternatively, the different types of gangliosides might act mutually compensatory in supporting transmitter release. Such a compensatory action of GM3 ganglioside might explain the redundancy we found for the other gangliosides, because in all three investigated transgenic strains at least this ganglioside remains present in the neural membrane (Fig. 1) , most likely at highly accumulated level (Inoue et al., 2002) . We here acutely removed the sialic acid component of this only remaining ganglioside at dKO NMJs, thereby creating a ganglioside-free nerve terminal, and studied the effect on transmitter release.
Gangliosides are glycosphingolipids that bear one or more sialic acid residues. This family of amphipathic molecules resides in the outer layer of cell membranes and is especially enriched in presynaptic nerve endings (for review, see Plomp and Willison, 2009) . Hence, gangliosides have been hypothesized to play important roles in synaptic transmission, possibly through affecting presynaptic voltage-gated ion channels, Ca 2+ -homeostasis and/or surface charge.
However, at the neuromuscular junction (NMJ) of transgenic mice lacking major subsets of gangliosides ( Fig. 1) , we have previously shown that presence of the complete family of gangliosides is not strictly required for functional synaptic transmission. Electrophysiological measurement of acetylcholine (ACh) release at NMJs of GM2/GD2-synthase knockout (GM2s-KO), GD3-synthase knockout (GD3s-KO), or compound null-mutant mice lacking both GM2/GD2-and GD3-synthase (dKO), showed only subtle changes and no failure of synaptic transmission was observed (Bullens et al., 2002; Zitman et al., 2008; Zitman et al., 2009 ). This suggests a fine-tuning role for gangliosides in transmitter release, rather than their presence being an absolute requirement. Alternatively, the different types of gangliosides might act mutually compensatory in supporting transmitter release. Such a compensatory action of GM3 ganglioside might explain the redundancy we found for the other gangliosides, because in all three investigated transgenic strains at least this ganglioside remains present in the neural membrane ( Fig. 1) , most likely at highly accumulated level (Inoue et al., 2002) . We here acutely removed the sialic acid component of this only remaining ganglioside at dKO NMJs, thereby creating a ganglioside-free nerve terminal, and studied the effect on transmitter release.
Male and female dKO mice (Inoue et al., 2002; Zitman et al., 2008) were used in the experiments, at ~11 weeks of age and 22.9 ± 1.1 g body weight. Mice were killed by CO 2 asphyxiation. Left and right hemidiaphragms with phrenic nerves were dissected and pinned out in Ringer's medium (119 mM NaCl, 4.5 mM KCl, 2 mM CaCl 2 , 1 mM MgSO 4 , 1mM NaH 2 PO 4 , 23 mM NaHCO 3 , 11 mM glucose, pH 7.4), pre-gassed with 95% O 2 /5% CO 2 .
Animal experiments were carried out according to Dutch law and Leiden University guidelines.
dKO phrenic nerve-hemidiaphragm preparations (6 left-and 4 right-hemidiaphragms from n=10 dKO mice) were treated with 2 units neuraminidase type V from Clostridium perfringens (Sigma-Aldrich, Zwijndrecht, The Netherlands) in 1 ml Ringer's medium for 1 h at 32 °C. This disrupts GM3 by cleaving the α2,3-link between the sialic acid and galactose molecule (Perillo et al., 1994) . We used tissue from dKO mice because neuraminidase treatment of wild-type tissue will not induce complete ganglioside ablation due to the inability of the neuraminidase to desialylate GM1 (Perillo et al., 1994) . The contralateral hemidiaphragm from each mouse was incubated as a control in Ringer's medium only.
Preparations were then rinsed in Ringer's medium for 10 min. Subsequently, μ-conotoxin-GIIIB (3 μM; Scientific Marketing Associates, Barnet, Herts, UK) was added to block voltage-gated Na + channels on the muscle membrane in order to prevent muscle action potentials and contraction. ACh release at NMJs at room temperature (20-22 C) was assessed using an intracellular electrophysiological method, as described before (Zitman et al., 2008) 2C-E). For comparison, EPP rundown level at wild-type NMJs under comparable experimental conditions in our previous study was 80.9  1.2% (Zitman et al., 2008) .
Furthermore, the increase of the second EPP of the 40 Hz evoked train, compared to the first EPP (i.e. 25 ms paired-pulse facilitation), was lower in the neuraminidase-treated group (3.35  0.66% at control vs. 0.32  0.50% at neuraminidase-treated dKO NMJs; p<0.01; Fig. 2F ).
These results show that acute absence of all gangliosides by in vitro disruption of GM3, the only remaining type of ganglioside at dKO NMJs, at the one hand increases presynaptic neurotransmitter release by enhancing the amount of ACh released per nerve impulse but, on the other hand, reduces release by causing a more pronounced rundown during high rate stimulation. It is yet unclear how gangliosides affect ACh release in this way. Possibly it involves a modulatory effect of the negative electrical charges carried by sialic acid molecules of gangliosides on the presynaptic Ca v 2.1 channels that mediate neurotransmitter release at the NMJ (Kaja et al., 2007) . This type of channel has been shown to co-localize with gangliosides in lipid rafts (Taverna et al., 2004) , which may facilitate interaction.
Furthermore, experiments using anti-ganglioside antibodies suggest a relationship between gangliosides and Ca v 2.1 channels (Nakatani et al., 2009; Ortiz et al., 2001) . Ca v 2.1 channel behaviour is one important determinant of EPP rundown level at high intensity use of NMJs (Kaja et al., 2005) . Another indication for possible modulation of Ca v 2.1 channels by gangliosides is the reduction of 25 ms paired-pulse facilitation, because this phenomenon of short term synaptic plasticity is highly dependent on intraterminal accumulation of Ca 2+ , mainly determined by influx levels and intracellular buffering capacity. Increased Ca 2+ influx following neuraminidase treatment has also been shown in cardiac myocytes, possibly through opening of 'leak' channels (Marengo et al., 1998) . Alternatively, the sialic acids of gangliosides adjacent to presynaptic Ca v 2.1 channels at the motor nerve terminal might act to locally sequester extracellular Ca 2+ , making it available upon high intensity use of the synapse in order to enable sustained transmitter release.
Although we are not aware of any sialylated proteins important for presynaptic transmitter release at mouse NMJs, we can not completely exclude that (part) of the effects of neuraminidase treatment on synaptic transmission at the dKO NMJs was due to desialylation of such putative sialoproteins. Sialic acid removal from hippocampal voltage-gated Na + channels has been shown to increase action potential firing threshold (Isaev et al., 2007) .
However, such an effect occurring in phrenic nerves of our nerve-muscle preparations would be irrelevant because of the supramaximal stimulation we applied.
In view of the rather modest magnitude of the effects of total ganglioside ablation on ACh release, in combination with the increased initial quantal content, compensating for the reduced release at high rate stimulation, it is not to be expected that successful neuromuscular transmission becomes endangered. Synaptic transmission at the NMJ has a large safety factor (Wood and Slater, 2001) , and in line with this we observed a sustained tetanic muscle contraction upon 40 Hz nerve stimulation when visually inspecting dKO hemidiaphragms directly after the neuraminidase treatment.
In conclusion, we show that gangliosides play a role in transmitter release at the NMJ, albeit a rather modest one. Although an indispensable role for gangliosides in neurotransmission was hypothesized previously, they apparently are not absolutely required. The almost normal ACh release levels observed earlier at NMJs of GM2s-KO, GD3s-KO and dKO mice (Bullens et al., 2002; Zitman et al., 2008; Zitman et al., 2009 ) are likely due to compensatory effects of the remaining subsets of gangliosides, or GM3 ganglioside alone, respectively. It must be noted that we here studied synaptic effects of acute ablation of the last remaining ganglioside at dKO NMJs and that it can not be excluded that long-term overall ganglioside deficiency has more severe synaptic effects. Such effects may underlie the severe neurodegenerative symptoms and premature death of transgenic mice lacking both GM2-synthase and GM3-synthase, which have permanently blocked in vivo synthesis of all gangliosides (Yamashita et al., 2005) . In humans it was found that a lack of synthesis of the major gangliosides, due to a autosomal recessive truncation mutation in the SIAT9 gene that encodes GM3-synthase, resulted in infantile-onset epilepsy associated with developmental stagnation and blindness (Simpson et al., 2004) . The affected children show distorted reflexes and one case of startle myoclonus was observed. Neuromuscular transmission failure has not specifically been reported in these patients. 
